All aspects of CMT, as an inherited neuromuscular disease, were covered: from basic science to genetic diagnosis and clinical management, therapy development, clinical outcome measures and clinical trials, as well as technical aspects like data sharing and AI.
A main priority for the meeting is mentorship and development of junior scientists and clinicians. To that end, part of the money raised to support the Conference was used for fellowships for junior attendees as has been done in the past.
